DEMYSTIFYING IMD EXPERTS DIALOGUE

Speciality: Physician (Internal Medicine)


Speaker:

Dr. Vijay Yewale - Moderator | Director and Consultant Pediatrician

Dr. Rashna Dass Hazarika - Panellist | Chief Pediatrics & Neonatology

Dr. Jaydeep Choudhury - Panellist | Consultant Pediatrician

Dr. Sachin Jain - Panellist | (Microbiologist)

Description:

A warm welcome to all the medical professionals in this interesting session on demystifying IMD experts dialogue

In the realm of healthcare, the dialogue among interdisciplinary medical professionals is crucial for advancing patient care and medical research. These discussions, often termed IMD (Interdisciplinary Medical Dialogue), involve specialists from various fields collaborating to tackle complex medical issues. By sharing their diverse perspectives and expertise, these experts can develop comprehensive treatment plans that address the multifaceted nature of patient conditions.

Demystifying IMD requires an understanding of the communication dynamics among healthcare professionals. Each specialist brings unique insights based on their training and experience, creating a rich tapestry of knowledge. This collaborative approach not only enhances the decision-making process but also fosters innovation in treatment methodologies.

Moreover, effective communication in IMD helps bridge gaps between disciplines, ensuring that all relevant aspects of a patient's health are considered. By breaking down silos and encouraging open dialogue, healthcare teams can improve patient outcomes and optimize resource utilization.
Therefore, get an overall knowledge of demystifying IMD experts dialogue. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Remote monitoring can improve recovery from cancer surgery

2.

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

3.

A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials

4.

Conditional EU Nod for Weekly Pill in Pediatric Glioma

5.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot